In this study, the effectiveness of the Dornase Alpha treatment, which is known to reduce the
viscosity of respiratory secretions, will be investigated in new diagnosed and severe
COVID-19 patients separately.
Phase:
Phase 2
Details
Lead Sponsor:
Acibadem University
Collaborator:
The Scientific and Technological Research Council of Turkey